custirsen

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Docetaxel and cabazitaxel improve overall survival compared with mitoxantrone in patients with metastatic castration… Expand
Is this relevant?
2017
2017
BACKGROUND Clusterin is a chaperone protein associated with treatment resistance and upregulated by apoptotic stressors such as… Expand
Is this relevant?
2017
2017
AIMS Custirsen (OGX-011/TV-1011), a second-generation antisense oligonucleotide that reduces clusterin production, is under… Expand
  • table 2
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2015
2015
AIMS Custirsen (OGX-011/TV-1011), a second-generation antisense oligonucleotide (ASO) that reduces clusterin production, is under… Expand
Is this relevant?
2015
2015
5009 Background: Clusterin is a chaperone protein associated with treatment resistance and upregulated by apoptotic stressors… Expand
Is this relevant?
2013
2013
Elevated levels of clusterin (CLU), a stress-induced and secreted cytoprotective chaperone, are associated with advanced tumor… Expand
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • table 1
Is this relevant?
2012
2012
PURPOSE Clusterin (CLU), an antiapoptotic, stress-associated protein, confers resistance to therapy when overexpressed. This… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE Clusterin (CLU) is an antiapoptotic, stress-induced protein conferring treatment resistance when overexpressed. This… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2011
2011
TPS180 Background: Custirsen (OGX-011) is a second generation antisense oligonucleotide (ASO) with a prolonged tissue half-life… Expand
Is this relevant?
2008
2008
5002 Background: There is no standard of care when pts with metastatic HRPC manifest disease progression (PD) after 1st-line… Expand
Is this relevant?